Efficacy of silver nanoparticles in chronic periodontitis patients: a clinico-microbiological study
Introduction: Recent advances in nanotechnology have introduced new therapeutic materials for periodontal therapy. Previous studies showed that nanoparticles of silver provide high antibacterial activity. Taking this in consideration, it can be used in nonsurgical periodontal therapy. The present study focuses on efficacy of subgingival local drug delivery of silver nanoparticles in comparison with tetracycline in chronic periodontitis.
Methods: To understand the effect of silver nanoparticles and tetracycline gel in chronic periodontitis, patients which were divided in different: Group A: Scaling and root planning (SRP) with sub-gingival delivery of silver nanoparticles gel, Group B: SRP with sub-gingival delivery of tetracycline gel and Group C: SRP alone. The other data recorded was Plaque Index (PI), Gingival Index (GI), Probing Pocket Depth (PPD) and Clinical Attachment Level (CAL) at baseline (just before placement of gel), 1 month and 3 months of application of gel. Microbiological evaluation (Colony Forming Units, CFU) were recorded at baseline and after 3 months.
Results: The results showed that the use of silver nanoparticles delivery after SRP was as efficacious as tetracycline subgingival delivery to treat chronic periodontitis patients. All the clinical as well as microbiological parameters showed statistically significant difference from baseline to 3 months in all the groups.
Conclusions: As compared to other therapeutic modalities employed against infection, silver nanoparticles gel is non-toxic at given concentration, has no side effects and does not require complicated application method or any complex armamentarium. It is well tolerated and well accepted by the patients. Silver nanoparticles gel with SRP gives promising results and it can definitely aid in periodontal diseases.
1. Freitas RA. Personal choice in the coming era of nanomedicine. In: Allhoff F, Lin P, Moor JH, Weckert J, Roco MC. Nanoethics: The ethical and social implications of nanotechnology. New York: John Wiley & Sons; 2007:161-72.
2. Sanz I, Alonso B, Carousel M, Herrera MD, Sanz M. Nonsurgical treatment of periodontitis. J Evid-Based Dental Pract 2012;12 (3 Suppl.):76‐86. doi: 10.1016/S1532-3382(12)70019-2.
3. Greenstein G, Polson A. The Role of Local Drug Delivery in the Management of Periodontal Diseases: A Comprehensive Review. J Periodontol 1998;69(5):507-20. doi: 10.1902/jop.1922.214.171.1247.
4. Manjunath SH, Jones AH, Gabhane M. Local drug delivery systems in periodontal treatment: A review. Sch J Dent Sci. 2017;4(10):440-3. doi: 10.21276/sjds.2017.4.10.6.
5. Dorfer CE. Antimicrobials for the treatment of aggressive periodontitis. Oral Dis. 2003;9(1):51-3. doi: https://doi.org/10.1034/j.1601-0825.9.s1.9.x.
6. Slots J, Rosling BG. Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline. J Periodontol. 1986;10(5):465-86. doi: 10.1111/j.1600-051x.1983.tb02179.x.
7. Gordon JM, Walker CB, Murphy JC, Goodson JH, Socransky SS. Concentration of tetracycline in human gingival fluid after single doses. J Clin Periodontol.1981;8(2):117-21. doi: 10.1111/j.1600-051x.1981.tb02351.x.
8. Golub LM, Greenwald RA, Ramamurthy NS, McNamara TF, Rifkin BR. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med. 1991;2(3):297-321. doi: https://doi.org/10.1177/10454411910020030201.
9. Maze GI, Reinhardt RA, Payne JB, Maze C, Baker RA, Bouwsma OJ, et al. Gingival fluid tetracycline release from bioerodible gels. J Clin Periodontol. 1996;23(12):1133-6. doi: https://doi.org/10.1111/j.1600-051x.1996.tb01815.x
10. Baker PJ, Evans RT, Slots J, Genco RJ. Antibiotic susceptibility of anaerobic bacteria from the human oral cavity. J Dent Res. 1985;64(10):1233-44. doi: https://doi.org/10.1177/00220345850640101201.
11. Auffan M, Rose J, Bottero JY, Lowry GW, Jolivet JP, Wiesner MR. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat Nanotechnol. 2009;4(10):634-41. doi: 10.1038/nnano.2009.242.
12. Kale S, Mahale S, Sonar P. Antimicrobial Efficacy of Silver Nanoparticles Against Periodontal Pathogens. Int J Current Adv Res. 2018;7:13457-60. doi: http://dx.doi.org/10.24327/ijcar.2018.13460.2403.
13. Patel NA, Patel NJ, Patel RP. Formulation and evaluation of curcumin gel for topical application. Pharm Dev Technol. 2009;14(1):80-9. doi: 10.1080/10837450802409438.
14. Lowenguth RA, Greenstein G. Clinical and microbiological response to non-surgical mechanical periodontal therapy. Periodontol 2000. 1995;9:14-22. doi: 10.1111/j.1600-0757.1995.tb00052.x.
15. George RP, Kumar S, Ramakrishna T, Emmadi P, Ambalavanan N. Effects of tetracycline-containing gel and a mixture of tetracycline and citric acid-
containing gel on non-surgical periodontal therapy. Indian J Dent Res. 2013;24(1):52-9. doi: 10.4103/0970-9290.114949.
16. Mayfield L, Bratthall G, Attström R. Periodontal probe precision using 4 different periodontal probes. J Clin Periodontol. 1996;23(2):76-82. doi: 10.1111/j.1600-051x.1996.tb00538.x.
17. Masurkar SA, Chaudhari PR, Shidore VB, Kamble SP. Effect of biologically synthesised silver nanoparticles on Staphylococcus aureus biofilm quenching and prevention of biofilm formation. IET Nanobiotechnol. 2012;6(3):110-4. doi: 10.1049/iet-nbt.2011.0061.
18. Prasetyo BC, Sugiharti RJ, Mahendra I, Halimah I, Widyasar EM, Rusminah N, et al. Evaluation of Silver Nanoparticles Addition in Periodontal Dressing for Wound Tissue Healing by 99mTc-ciprofloxacin. J Young Pharm. 2019;11(1):17-20. doi:10.5530/jyp.2019.11.4.
19. Habiboallah G, Mahdi Z, Majid Z, Narroallah S, Taghavi AM, Forouzanfar A, et al. Enhancement of gingival wound healing by local application of silver nanoparticles periodontal dressing following surgery: a histological assessment in animal model. Mod Res Inflam. 2014;3:128-38. doi: 10.4236/mri.2014.33016.
20. Tian X, Jiang X, Welch C, Croley TR, Wong TY, Chen C. Bactericidal effects of silver nanoparticles on lactobacilli and the underlying mechanism. ACS Appl Mater Interfaces. 2018;10(10):8443-50. doi: 10.1021/acsami.7b17274.
21. Jeong SN, Han SB, Lee SW, Magnusson I. Effects of tetracycline-containing gel and a mixture of tetracycline and citric acid-containing gel on non-surgical periodontal therapy. J Periodontol. 1994;65(9):840-7. doi: 10.1902/jop.19126.96.36.1990.
22. Sadeghi R, Olia P, Rezvani MB, Taleghani F, Sharif F. Comparison of the nanosilver and chlorhexidine antimicrobial effect on Streptococcus sanguis and actinomicosis viscosus. J Islamic Dent Assoc. 2010;23:225-31.
23. Monteiro DR, Gorup LF, Takamiya AS, Ruvollo-Filho AC, de Camargo ER, Barbosa DB. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int J Antimicrob Agents. 2009;34(2):103-10. doi: 10.1016/j.ijantimicag.2009.01.017.
24. Bonito AJ, Lux L, Lohr KN. Impact of local adjuncts to scaling and root planing in periodontal disease therapy: a systematic review. J Periodontol. 2005;76(8):1227-36. doi: 10.1902/jop.2005.76.8.1227.
25. Shao J, Yu N, Kolwijck E, Wang B, Tan KW, Jansen JA, et al. Biological evaluation of silver nanoparticles incorporated into chitosan-based membranes. Nanomedicine. 2017;12(22):2771-85. doi: 10.2217/nnm-2017-0172.
26. Susanto C, Ervina I, Agusnar H. In vitro evaluation of antimicrobial effectiveness chitosan based tetracycline gel on some pathogenic periodontal bacteria. Int J Appl Dent Sci 2017;3(2):71-6.
27. Bosco JM, Lopes BM, Bosco AF, Spolidorio DM, Marcantonio RA. Local application of tetracycline solution with a microbrush: An alternative treatment for persistent periodontitis. Quintessence Int. 2009;40(1):29-40.